GetPortalImpactFactorByIdResp(projectId=1, id=77151967, cover=https://img.medsci.cn/images/journal/cover/2021/Say_202109271315240480.jpg, fullname=INTERNATIONAL JOURNAL OF PHARMACEUTICS, abbr=INT J PHARMACEUT, pyear=1978, frequence=Semimonthly, articleNumbers=11051, citedSelf2015=11.5, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2.5月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0378-5173, greenSci=https://www.greensci.net/search?kw=0378-5173, scijournal=https://www.scijournal.org/impact-factor-of-INT-J-PHARMACEUT.shtml, medsciHotlightString=null, medsciHotlightRealtime=11.468, medsciHotlight=13.501, medsciHotlight5year=18.1287, citescore=8.6, hIndex=217, impactFactor=5.8, orgnization=Elsevier, orgnizationUrl=http://www.elsevier.com, country=Netherlands, countryCn=荷兰, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 2区[Top], smallclassCas=医学 2 区, website=https://www.elsevier.com/wps/find/journaldescription.cws_home/505513/description, websiteHits=21091, guideForAuthor=null, guideForAuthorHits=17, submitWebsite=https://www.editorialmanager.com/ijp/|https://www.editorialmanager.com/ijp/, submitWebsiteHits=8799, content=The International Journal of Pharmaceutics provides a medium for the publication of innovative papers, reviews, mini-reviews, short communications and notes dealing with physical, chemical, biological, microbiological and engineering studies related to the conception, design, production, characterisation and evaluation of drug delivery systems in vitro and in vivo. "Drug" is defined as any therapeutic or diagnostic entity, including oligonucleotides, gene constructs and radiopharmaceuticals. Areas of particular interest include: physical pharmacy; polymer chemistry and physical chemistry as applied to pharmaceutics; excipient function and characterisation; biopharmaceutics; absorption mechanisms; membrane function and transport; novel routes and modes of delivery; responsive delivery systems, feedback and control mechanisms including biosensors; applications of cell and molecular biology to drug delivery; prodrug design; bioadhesion (carrier-ligand interactions); and biotechnology (protein and peptide delivery). Editorial Policy The over-riding criteria for publication are originality, high scientific quality and interest to a multidisciplinary audience. Papers not sufficiently substantiated by experimental detail will not be published. Any technical queries will be referred back to the author, although the Editors reserve the right to make alterations in the text without altering the technical content. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur with the submission and that a copy of the final manuscript has been approved by all authors and tacitly or explicitly by the responsible authorities in the laboratories where the work was carried out. If accepted, the manuscript shall not be published elsewhere in the same form, in either the same or another language, without the consent of the Editors and Publisher. Authors must state in a covering letter when submitting papers for publication the novelty embodied in their work or in the approach taken in their research. Routine bioequivalence studies are unlikely to find favour. No paper will be published which does not disclose fully the nature of the formulation used or details of materials which are key to the performance of a product, drug or excipient. Work which is predictable in outcome, for example the inclusion of another drug in a cyclodextrin to yield enhanced dissolution, will not be published unless it provides new insight into fundamental principles., totalCites=64101, brief=INT J PHARMACEUT杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=绝大部分收录论著，也接收少量其它类型文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=INT J PHARMACEUT 在该细分领域可能是国际一流杂志，但是国内关注少，可能与很难投中有关吧，可以试试，但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=77151967'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=41472, tagName=药剂学, createdHits=2), ImpactFactorTagDto(id=112, tagName=药学, createdHits=2), ImpactFactorTagDto(id=1895, tagName=靶向药物, createdHits=2), ImpactFactorTagDto(id=17866, tagName=纳米药物, createdHits=2), ImpactFactorTagDto(id=9435, tagName=脂质体, createdHits=2), ImpactFactorTagDto(id=41486, tagName=生物药剂学, createdHits=1), ImpactFactorTagDto(id=11076, tagName=生物技术, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=4.24), GetImpactFactorCiteScoreListResponse(year=2017, citescore=4.06), GetImpactFactorCiteScoreListResponse(year=2018, citescore=4.35), GetImpactFactorCiteScoreListResponse(year=2019, citescore=7.6), GetImpactFactorCiteScoreListResponse(year=2020, citescore=8.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=15.681), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=16.056), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=13.717), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=11.816), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=11.468)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science , rank=15/164)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-5173[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=INTERNATIONAL JOURNAL OF PHARMACEUTICS[ta], article_number=953, article_number_cn=195, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)